Funding tracker
Ansa Biotechnologies raised $71.5M
$71.5MRaised
Series CStage
18 Nov 2026Date
127Views on the announcement
The round
| Amount | $71.5M |
|---|---|
| Stage | Series C |
| Investors | not stated |
| What they do | Enzymatic DNA synthesis |
| Vertical | Health and bio |
| First reported | Wednesday, 18 November 2026 |
The announcement on X
The median tracked announcement from accounts with under 10K followers reached 13.4K views (201 posts). This one did 0.01x that.
Ansa Biotechnologies has closed a $71.5 million oversubscribed Series C financing, bringing our total funding to $211 million. Read the full press release at https://t.co/W47INyXvTt https://t.co/8f9FZe8M9S
| Posted by | @AnsaBio (Ansa Biotechnologies) |
|---|---|
| Followers | 1,376 |
| Views | 127 |
| Views per follower | 0.09x |
| Likes | 4 |
| Reposts | 0 |
| Bookmarks | 0 |
Similar rounds
| Company | Stage | Amount | Lead | On X | Date |
|---|---|---|---|---|---|
| IsomorphicAI drug discovery | Series C | $5B | - | - | 18 Nov 2026 |
| PayhawkSpend management platform | Series C | $280M | Goldman Sachs, Goldman Sachs Growth | - | 18 Nov 2026 |
| BoltzAI drug design software | Series A | $110M | Bessemer | 61.1K | 18 Nov 2026 |
| TesoraiAI-powered life sciences research platform | Seed | $5.3M | - | 31 | 18 Nov 2026 |
| PulmoGateNagoya University AI spinout | Seed | $3.3M | - | - | 18 Nov 2026 |
| Science Corporation | Series D | $400M | - | - | 17 Nov 2026 |
Next launch
Planning a launch?
Tell us what is launching and when. Thirty minutes is usually enough to know whether we are the right team for it.